Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
-
Shares outstanding
-
49,720,826
-
Total 13F shares
-
7,328,435
-
Share change
-
-221,505
-
Total reported value
-
$131,544,000
-
Price per share
-
$17.95
-
Number of holders
-
27
-
Value change
-
-$3,975,474
-
Number of buys
-
16
-
Number of sells
-
5
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q4 2020
As of 31 Dec 2020,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,328,435 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Point72 Asset Management, L.P., Atlas Venture Advisors, Inc., SAMLYN CAPITAL, LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, AXA S.A., RENAISSANCE TECHNOLOGIES LLC, and MOODY ALDRICH PARTNERS LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.